Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
NEWS
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...